Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wenxing You"'
Autor:
Franky Leung Chan, Shan Yu, Chi-Fai Ng, Wenxing You, Zhu Wang, Dinglan Wu, Zhenyu Xu, Hao Hu, Kexin Xu, Yuliang Wang, Lijia Xiao
Supplementary Methods and Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de77654b91bd249b4277bba781df4c48
https://doi.org/10.1158/0008-5472.22419011
https://doi.org/10.1158/0008-5472.22419011
Autor:
Franky Leung Chan, Shan Yu, Chi-Fai Ng, Wenxing You, Zhu Wang, Dinglan Wu, Zhenyu Xu, Hao Hu, Kexin Xu, Yuliang Wang, Lijia Xiao
Targeting of steroidogenic enzymes (e.g., abiraterone acetate targeting CYP17A1) has been developed as a novel therapeutic strategy against metastatic castration-resistant prostate cancer (CRPC). However, resistance to steroidal inhibitors inevitably
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dbb9e2e183e1a87116d060f923092a5
https://doi.org/10.1158/0008-5472.c.6510275.v1
https://doi.org/10.1158/0008-5472.c.6510275.v1
Autor:
Franky Leung Chan, Shan Yu, Chi-Fai Ng, Wenxing You, Zhu Wang, Dinglan Wu, Zhenyu Xu, Hao Hu, Kexin Xu, Yuliang Wang, Lijia Xiao
Supplementary Tables S1-S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34dbdf53b429b4ed7e0b2b0b2829a1e
https://doi.org/10.1158/0008-5472.22419008.v1
https://doi.org/10.1158/0008-5472.22419008.v1
Autor:
Franky Leung Chan, Shan Yu, Chi-Fai Ng, Wenxing You, Zhu Wang, Dinglan Wu, Zhenyu Xu, Hao Hu, Kexin Xu, Yuliang Wang, Lijia Xiao
Supplementary Figures S1-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5282a0f2d5b06f69cb8f26aafbba1e
https://doi.org/10.1158/0008-5472.22419014.v1
https://doi.org/10.1158/0008-5472.22419014.v1
Autor:
Alissa Michelle Wong, Xiaofan Ding, Aikha Melissa Wong, Mingjing Xu, Luyao Zhang, Howard Ho-Wai Leung, Anthony Wing-Hung Chan, Qi Xiu Song, Joseph Kwong, Loucia Kit-Ying Chan, Matthew Man, Mian He, Jinna Chen, Zhe Zhang, Wenxing You, Coleen Lau, Allen Yu, Yingying Wei, Yunfei Yuan, Paul Bo-San Lai, Jingmin Zhao, Kwan Man, Jun Yu, Michael Kahn, Nathalie Wong
Background & Aims\ud Metabolic syndrome can lead to the clinical manifestation of non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC) as part of the natural history of NAFLD. Despite a strong causative link, NAFLD-HCC is ofte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::889e40976067d3386f560a46841c41c7
https://eprints.keele.ac.uk/10830/1/PIIS0168827822001842.pdf
https://eprints.keele.ac.uk/10830/1/PIIS0168827822001842.pdf
Autor:
Mingjing Xu, Yue Liu, Ho Lee Wan, Alissa M. Wong, Xiaofan Ding, Wenxing You, Wing Sze Lo, Kelvin K-C Ng, Nathalie Wong
Publikováno v:
Cancer letters. 548
Uracil misincorporation during DNA replication is a major cell toxic event, of which cancer cells overcome by activating the dUTPase enzyme. The DUT gene is the only known dUTPase in human. Despite reports on common upregulations in cancers, the role
Autor:
Shisong Han, Youhua Tan, Wai Ki Ricky Wong, Nathalie Wong, Xintao Shuai, Limei Xu, Xi Chen, Liming Bian, Wenxing You, Xuemei Wang, Ying Xin, Siu Hong Dexter Wong, Jiwon Oh, Li Duan, Xiao Xu, Chun Him Nathanael Lai
Publikováno v:
Nano letters. 21(7)
Developing strategies for efficient expansion of cancer stem-like cells (CSCs) in vitro will help investigate the mechanism underlying tumorigenesis and cancer recurrence. Herein, we report a dynamic culture substrate tethered with integrin ligand-be
Autor:
Wenxing You, p> sup>
Publikováno v:
Frontiers in Art Research. 3
Inquiry learning has been a main content of the current basic education reform, and art teaching is the main part of ordinary senior high school teaching. For a long time, due to the single pursuit of enrollment rate, the art teaching methods in seni
Autor:
Zhenyu Xu, Kexin Xu, Chi-Fai Ng, Zhu Wang, Wenxing You, Dinglan Wu, Franky L. Chan, Shan Yu, Lijia Xiao, Yuliang Wang, Hao Hu
Publikováno v:
Cancer Research. 78:2205-2218
Targeting of steroidogenic enzymes (e.g., abiraterone acetate targeting CYP17A1) has been developed as a novel therapeutic strategy against metastatic castration-resistant prostate cancer (CRPC). However, resistance to steroidal inhibitors inevitably
Autor:
Lin Jia, Lijia Xiao, Franky L. Chan, Zhu Wang, Chi-Fai Ng, Zhenyu Xu, Fei Wang, Yuliang Wang, Wenxing You, Dinglan Wu, Ganhui Cai, Shan Yu, Jeremy Yuen-Chun Teoh, Chang Zou
Publikováno v:
Oncogene
The metastatic castration-resistant prostate cancer (CRPC) is a lethal form of prostate cancer, in which the expression of androgen receptor (AR) is highly heterogeneous. Indeed, lower AR expression and attenuated AR signature activity is shown in CR